Explores the development and challenges of antibody-based therapeutics, including chimeric and humanized antibodies, alternative scaffolds, and in vitro selection.
Introduces the emerging field of immunoengineering, covering interactions between engineering and immunology, genetically engineered immune cells for cancer therapy, and key technologies in immunological analysis.
